利用转录组学分析和生物物理模型研究肿瘤和循环肿瘤细胞的上皮-间质异质性

Federico Bocci, Susmita Mandal, Tanishq Tejaswi, Mohit Kumar Jolly
{"title":"利用转录组学分析和生物物理模型研究肿瘤和循环肿瘤细胞的上皮-间质异质性","authors":"Federico Bocci,&nbsp;Susmita Mandal,&nbsp;Tanishq Tejaswi,&nbsp;Mohit Kumar Jolly","doi":"10.1002/cso2.1015","DOIUrl":null,"url":null,"abstract":"<p>Cellular heterogeneity along the epithelial-mesenchymal plasticity (EMP) spectrum is a paramount feature observed in tumors and circulating tumor cells (CTCs). High-throughput techniques now offer unprecedented details on this variability at a single-cell resolution. Yet, there is no current consensus about how EMP in tumors propagates to that in CTCs. To investigate the relationship between EMP-associated heterogeneity of tumors and that of CTCs, we integrated transcriptomic analysis and biophysical modeling. We apply three epithelial-mesenchymal transition (EMT) scoring metrics to multiple tumor samples and CTC datasets from several cancer types. Moreover, we develop a biophysical model that couples EMT-associated phenotypic switching in a primary tumor with cell migration. Finally, we integrate EMT transcriptomic analysis and in silico modeling to evaluate the predictive power of several measurements of tumor aggressiveness, including tumor EMT score, CTC EMT score, fraction of CTC clusters found in circulation, and CTC cluster size distribution. Analysis of high-throughput datasets reveals a pronounced heterogeneity without a well-defined relation between EMT traits in tumors and CTCs. Moreover, mathematical modeling predicts different phases where CTCs can be less, equally, or more mesenchymal than primary tumor depending on the dynamics of phenotypic transition and cell migration. Consistently, various datasets of CTC cluster size distribution from different cancer types are fitted onto different regimes of the model. By further constraining the model with experimental measurements of tumor EMT score, CTC EMT score, and fraction of CTC cluster in bloodstream, we show that none of these assays alone can provide sufficient information to predict the other variables. In conclusion, we propose that the relationship between EMT progression in tumors and CTCs can be variable, and in general, predicting one from the other may not be as straightforward as tacitly assumed.</p>","PeriodicalId":72658,"journal":{"name":"Computational and systems oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/cso2.1015","citationCount":"0","resultStr":"{\"title\":\"Investigating epithelial-mesenchymal heterogeneity of tumors and circulating tumor cells with transcriptomic analysis and biophysical modeling\",\"authors\":\"Federico Bocci,&nbsp;Susmita Mandal,&nbsp;Tanishq Tejaswi,&nbsp;Mohit Kumar Jolly\",\"doi\":\"10.1002/cso2.1015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Cellular heterogeneity along the epithelial-mesenchymal plasticity (EMP) spectrum is a paramount feature observed in tumors and circulating tumor cells (CTCs). High-throughput techniques now offer unprecedented details on this variability at a single-cell resolution. Yet, there is no current consensus about how EMP in tumors propagates to that in CTCs. To investigate the relationship between EMP-associated heterogeneity of tumors and that of CTCs, we integrated transcriptomic analysis and biophysical modeling. We apply three epithelial-mesenchymal transition (EMT) scoring metrics to multiple tumor samples and CTC datasets from several cancer types. Moreover, we develop a biophysical model that couples EMT-associated phenotypic switching in a primary tumor with cell migration. Finally, we integrate EMT transcriptomic analysis and in silico modeling to evaluate the predictive power of several measurements of tumor aggressiveness, including tumor EMT score, CTC EMT score, fraction of CTC clusters found in circulation, and CTC cluster size distribution. Analysis of high-throughput datasets reveals a pronounced heterogeneity without a well-defined relation between EMT traits in tumors and CTCs. Moreover, mathematical modeling predicts different phases where CTCs can be less, equally, or more mesenchymal than primary tumor depending on the dynamics of phenotypic transition and cell migration. Consistently, various datasets of CTC cluster size distribution from different cancer types are fitted onto different regimes of the model. By further constraining the model with experimental measurements of tumor EMT score, CTC EMT score, and fraction of CTC cluster in bloodstream, we show that none of these assays alone can provide sufficient information to predict the other variables. In conclusion, we propose that the relationship between EMT progression in tumors and CTCs can be variable, and in general, predicting one from the other may not be as straightforward as tacitly assumed.</p>\",\"PeriodicalId\":72658,\"journal\":{\"name\":\"Computational and systems oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1002/cso2.1015\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Computational and systems oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cso2.1015\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Computational and systems oncology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cso2.1015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

上皮-间充质可塑性(EMP)谱上的细胞异质性是肿瘤和循环肿瘤细胞(ctc)的一个重要特征。高通量技术现在以单细胞分辨率提供了这种可变性的前所未有的细节。然而,目前对于肿瘤中的EMP如何传播到ctc中尚无共识。为了研究emp相关肿瘤异质性与ctc异质性之间的关系,我们整合了转录组学分析和生物物理模型。我们将三个上皮-间质转化(EMT)评分指标应用于多个肿瘤样本和来自几种癌症类型的CTC数据集。此外,我们开发了一种生物物理模型,将原发性肿瘤中emt相关的表型转换与细胞迁移耦合在一起。最后,我们整合了EMT转录组学分析和计算机建模,以评估肿瘤侵袭性的几种测量方法的预测能力,包括肿瘤EMT评分、CTC EMT评分、循环中发现的CTC簇的比例和CTC簇大小分布。对高通量数据集的分析显示,肿瘤中EMT特征与ctc之间存在明显的异质性,但没有明确的关系。此外,根据表型转变和细胞迁移的动态,数学模型预测了不同的阶段,ctc可能比原发肿瘤更少、相同或更多的间质性。一致地,来自不同癌症类型的CTC簇大小分布的各种数据集被拟合到模型的不同制度上。通过进一步用肿瘤EMT评分、CTC EMT评分和血液中CTC簇的分数的实验测量来约束模型,我们发现这些分析都不能单独提供足够的信息来预测其他变量。总之,我们认为肿瘤中EMT进展与ctc之间的关系可能是可变的,一般来说,预测一个与另一个之间的关系可能不像默认的那样简单。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Investigating epithelial-mesenchymal heterogeneity of tumors and circulating tumor cells with transcriptomic analysis and biophysical modeling

Investigating epithelial-mesenchymal heterogeneity of tumors and circulating tumor cells with transcriptomic analysis and biophysical modeling

Cellular heterogeneity along the epithelial-mesenchymal plasticity (EMP) spectrum is a paramount feature observed in tumors and circulating tumor cells (CTCs). High-throughput techniques now offer unprecedented details on this variability at a single-cell resolution. Yet, there is no current consensus about how EMP in tumors propagates to that in CTCs. To investigate the relationship between EMP-associated heterogeneity of tumors and that of CTCs, we integrated transcriptomic analysis and biophysical modeling. We apply three epithelial-mesenchymal transition (EMT) scoring metrics to multiple tumor samples and CTC datasets from several cancer types. Moreover, we develop a biophysical model that couples EMT-associated phenotypic switching in a primary tumor with cell migration. Finally, we integrate EMT transcriptomic analysis and in silico modeling to evaluate the predictive power of several measurements of tumor aggressiveness, including tumor EMT score, CTC EMT score, fraction of CTC clusters found in circulation, and CTC cluster size distribution. Analysis of high-throughput datasets reveals a pronounced heterogeneity without a well-defined relation between EMT traits in tumors and CTCs. Moreover, mathematical modeling predicts different phases where CTCs can be less, equally, or more mesenchymal than primary tumor depending on the dynamics of phenotypic transition and cell migration. Consistently, various datasets of CTC cluster size distribution from different cancer types are fitted onto different regimes of the model. By further constraining the model with experimental measurements of tumor EMT score, CTC EMT score, and fraction of CTC cluster in bloodstream, we show that none of these assays alone can provide sufficient information to predict the other variables. In conclusion, we propose that the relationship between EMT progression in tumors and CTCs can be variable, and in general, predicting one from the other may not be as straightforward as tacitly assumed.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.80
自引率
0.00%
发文量
0
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信